Skip to main content
SpringerLink
Log in

Chinese Expert Consensus on Clinical Application of Oral Ginkgo biloba Preparations (2020)

  • Regulation and Guideline
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Guo M, Liu Y, Xu L, et al. Cardiovascular pharmacological effects of traditional Chinese medicine ginkgo: mechanisms and prospects. Scientia Sinica Vitae (Chin) 2014;44:543–550.

    Article  Google Scholar 

  2. Kandiah N, Ong PA, Yuda T, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. CNS Neurosci Ther 2019;25:288–298.

    Article  PubMed  PubMed Central  Google Scholar 

  3. National Health Commission of the People’s Republic of China. National Essential Medicines List (2018 edition). http://www.nhc.gov.cn/ewebeditor/uploadfile/2018/10/20181025183346942.pdf.

  4. National Healthcare Security Administration. National Medicine List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2019 Edition): Chinese Patent Medicine. (2019-08-20)[2020-10-20]. http://www.nhsa.gov.cn/art/2019/8/20/art_37_1666.html.

  5. Guo M, Zhang Q, Yan LP, et al. Flavonoids as the main active ingredients of single herbs and compound Chinese medicines and their pharmacological activity. J Shenyang Med Coll (Chin) 2018;20:558–561, 564.

    Google Scholar 

  6. Ude C, Schubert-Zsilavecz M, Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin Pharmacokinet 2013;52:727–749.

    Article  CAS  PubMed  Google Scholar 

  7. van Beek TA, Montoro P. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J Chromatogr A 2009;1216:2002–2032.

    Article  CAS  PubMed  Google Scholar 

  8. Lamant V, Mauco G, Braquet P, et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987;36:2749–2752.

    Article  CAS  PubMed  Google Scholar 

  9. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China (2020, edition): Volume 1. Beijing: China Medical Science and Technology Press; 2020:434–436.

    Google Scholar 

  10. United States Pharmacopoeia Commission. United States Pharmacopoeia (2020 edition) 2020; USP. NF38:5038.

  11. European Pharmacopoeia Commission. European Pharmacopoeia (10th edition). 2020;1451-1453.

  12. National Medical Products Administration. National Drug Standards 2002; Ws3-227(Z-028) 2002z.

  13. Liu AH, Zhang ZX. Effects of Ginkgo biloba Extract 50 (GBE50) on the action potentials of papillary muscles in normal and ischemia model of guinea pigs. China J Chin Mater Med (Chin) 2010;35:2342–2345.

    CAS  Google Scholar 

  14. Lu S, Guo X, Zhao P. Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia-reperfusion rats. Molecules 2011;16: 9194–9206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Qiao ZY, Huang JH, Ma JW, et al. Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues. Mol Biol Rep 2014;41:347–353.

    Article  CAS  PubMed  Google Scholar 

  16. Liu A, Bao Y, Wang X, Zhang Z. Cardio-protection by Ginkgo biloba Extract 50 in rats with acute myocardial infarction is related to Na+-Ca2+ exchange. Am J Chin Med 2013;41:789–800.

    Article  PubMed  Google Scholar 

  17. Schneider R, Welt K, Aust W, et al. Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb761: I. Cardiomyocytes. Histol Histopathol 2008;23:807–817.

    PubMed  Google Scholar 

  18. Liu Y, Liu YF, Tian JF, et al. Cardiovascular protection mechanism of Ginkgo biloba extract on a rat model of type 2 diabetes after myocardial infarction. Chin J Integr Tradit West Med (Chin) 2017;37:1100–1104.

    Google Scholar 

  19. Tsai JY, Su KH, Shyue SK, et al. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res 2010;88:415–423.

    Article  CAS  PubMed  Google Scholar 

  20. Lim S, Yoon JW, Kang SM, et al. EGb761, a Ginkgo biloba Extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 2011;6:e20301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Tsai HY, Huang PH, Lin FY, et al. Ginkgo biloba Extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways. Eur J Pharm Sci 2013;48:803–811.

    Article  CAS  PubMed  Google Scholar 

  22. Zhu GY, Zhu W, Pan LY, et al. Effect of Ginkgo biloba Tablets on the expression of scavenger receptor A on in the aortic wall of atherosclerotic rats. Chin J Integr Tradit West Med (Chin) 2016;36:449–453.

    Google Scholar 

  23. Xu ZB, Wang WD, Zhang LF, et al. Experimental study on the intervention of Ginkgo biloba Capsules on the apoptosis of vascular endothelial cells in hyperhomocysteinemia. Chin J Integr Tradit West Med (Chin) 2015;35:1099–1104.

    Google Scholar 

  24. Sun WJ, Sun J, Chen BD, et al. Ginkgolide B inhibits hyperglycemia-induced TLR4 and inflammatory protein expression in endothelial cells. Chin Pharmacol Bull (Chin) 2015;31:636–640.

    CAS  Google Scholar 

  25. Li M, Bao YM, Liu AH, et al. Effect of Ginkgo biloba Extract 50 on ventricular remodeling in pressure-overloaded rats. Pharmacol Clin Chin Mater Med (Chin) 2013;29:78–82.

    CAS  Google Scholar 

  26. Jiang H, Qu P, Cui XQ et al. Effect of Ginkgo biloba Extract 50 on TLR4/NF- κB signaling mediated expression of angiotensinogene and angiotensin II type I receptor in cardiomyocytes. Chin J Hypertens (Chin) 2008;16:1013–1017.

    CAS  Google Scholar 

  27. Liu MY, Zhang LJ. Regulatory effect of Ginkgo biloba extract on 5-hydroxytryptamine and its receptors in mice with heart failure. Chin Med J (Chin) 2018;98:2024–2029.

    CAS  Google Scholar 

  28. Cho JH, Sung JH, Cho EH, et al. Gingko biloba Extract (EGb 761) prevents ischemic brain injury by activation of the Akt signaling pathway. Am J Chin Med 2009;37:547–555.

    Article  CAS  PubMed  Google Scholar 

  29. Sung JH, Shah FA, Cho EH, et al. Ginkgo biloba Extract (EGb 761) prevents the ischemic brain injury-induced decrease in parvalbumin expression. Lab Anim Res 2012;28:77–82.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Nada SE, Tulsulkar J, Shah ZA. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761®) after permanent ischemic stroke in mice. Mol Neurobiol 2014;49:945–956.

    Article  CAS  PubMed  Google Scholar 

  31. Tulsulkar J, Glueck B, Hinds TD, et al. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/Wnt pathway. Transl Stroke Res 2016;7:120–131.

    Article  PubMed  Google Scholar 

  32. Tulsulkar J, Shah ZA. Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochem Int 2013;62:189–197.

    Article  CAS  PubMed  Google Scholar 

  33. Zhang Z, Peng D, Zhu H, et al. Experimental evidence of Ginkgo biloba extract EGb as a neuroprotective agent in ischemia stroke rats. Brain Res Bull 2012;87:193–198.

    Article  CAS  PubMed  Google Scholar 

  34. Yuan R, Zhang YH, Cheng BL, et al. Effect of Ginkgo biloba extract 50 (EGb50) on the mitochondrial function of SH-SY5Y cells after hypoxia/reoxygenation injury. Chin J Chin Mater Med (Chin) 2018;43:4486–4490.

    Google Scholar 

  35. Hao L, Xu YY, Ren XH, et al. Effects of Ginkgo biloba Extract 50 on learning and memory in naturally aging rats and the expressions of c-fos, caspase-3 and caspase-8 in the hippocampus and prefrontal cortex. Pharmacol Clin Chin Mater Med (Chin) 2015;31:96–100.

    CAS  Google Scholar 

  36. Xia CY, Dong XW, Zhao Y, et al. Experimental study on the effects of Ginkgo biloba Extract 50 on cell damage caused by β-amyloid-induced oxidative stress in rat hippocampal neurons. Chin J Integr Tradit West Med (Chin) 2014;34:833–838.

    CAS  Google Scholar 

  37. Liu FQ, Gao Q, Wang DD, et al. Effects of Gingko Biloba Extract 50 on depression-like behavior and NLRP3 inflammasome in depressed rats. Acad J Shanghai Univ Tradit Chin Med (Chin) 2017;31:60–65.

    Google Scholar 

  38. He DF, Zhang LJ, Liu MY. Effects of drug treatment on sleep in zebrafish with insomnia and related mechanisms. Chin J Evid Based Cardiovasc Med (Chin) 2017;9:326–330.

    Google Scholar 

  39. Zhang L, Liu J, Ge Y, et al. Ginkgo biloba Extract reduces hippocampus inflammatory responses, improves cardiac functions and depressive behaviors in a heart failure mouse model. Neuropsychiatr Dis Treat 2019;15:3041–3050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sun T, Wang X, Xu H. Ginkgo biloba extract for angina pectoris: a systematic review. Chin J Integr Med 2015;21:542–550.

    Article  PubMed  Google Scholar 

  41. Chen H, Feng S, Chen HP, et al. Efficacy and safety of Ginkgo biloba Drop Pills in the treatment of angina: a systematic review of randomized controlled trials. Chin J New Drugs (Chin) 2019;28:2291–2298.

    Google Scholar 

  42. Zhao MJ, Ma LL, Li BF, et al. Systematic review and meta-analysis on the effectiveness of Ginkgo biloba Drop Pills combined with antihypertensive drugs in the treatment of primary hypertension. Chin J Evid Based Cardiovasc Med (Chin) 2019;11:910–913.

    Google Scholar 

  43. Chen H, Zhou C, Yu M, et al. The effect of Ginkgo biloba Dropping Pills on hemorheology and blood lipid: a systematic review of randomized trials. Evid Based Complement Alternat Med 2019;2019:2609625.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Song SQ, Wu YQ, Deng ZW, et al. Effect of Ginkgo biloba preparations on carotid artery ultrasound-related parameters in patients with carotid atherosclerosis. Pharmacol Clin Chin Mater Med (Chin) 2008;3:106–108.

    Google Scholar 

  45. Li S, Zhang X, Fang Q, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol 2017;2:189–197.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Chong PZ, Ng HY, Tai JT, et al. Efficacy and safety of Ginkgo biloba in patients with acute ischemic stroke: a systematic review and meta-analysis. Am J Chin Med 2020;48:513–534.

    Article  CAS  PubMed  Google Scholar 

  47. Aziz TA, Hussain SA, Mahwi TO, et al. The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial. Drug Des Dev Ther 2018;12:735–742.

    Article  CAS  Google Scholar 

  48. An XF, Zhao Y, Yu JY. Clinical observations on the prevention and treatment of early retinopathy in type 1 diabetes mellitus with Liuwei Dihuang Pills combined with Ginkgo biloba Tablets. Chin J Integr Tradit West Med (Chin) 2016;36:674–677.

    Google Scholar 

  49. Zheng WR, Han ZZ, Wang ZK, et al. Research advances in the safety Ginkgo biloba preparations. Modern Tradit Chin Med Materia Medica-World Sci Tech (Chin) 2019;21:437–443.

    Google Scholar 

  50. National Medical Products Administration. Announcement of the National Medical Products Administration on Revising the Instructions for Oral Preparations of Ginkgo biloba. Available at: http://www.cdr-adr.org.cn/drug_1/aqjs_1/drug_aqjs_smssggg/202001/t20200113_47040.html.

Download references

Author information

Authors
  1. Ke-ji Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Chinese Association of Integrative Medicine

Chinese Medical Doctor Association

National Clinical Research Center for Chinese Medicine Cardiology

Cardiovascular Disease Working Group

Encephalopathy Disease Working Group

China Center for Evidence-Based Chinese Medicine

Ethics declarations

None.

Additional information

Expert Consensus Writing Group

Expert Group Leader: CHEN Ke-ji (Xiyuan Hospital, China Academy of Chinese Medical Sciences)

Expert Group Members (arranged in surname stroke order): MAO Wei (Zhejiang Provincial Hospital of Chinese Medicine), YE Min (School of Pharmaceutical Sciences, Peking University), SHI Da-zhuo (Xiyuan Hospital, China Academy of Chinese Medical Sciences), QU Miao (Xuanwu Hospital, Capital Medical University), ZHU Ming-jun (First Affiliated Hospital of Henan University of Traditional Chinese Medicine), LI Xiao (Shandong Provincial Hospital of Traditional Chinese Medicine), LI Ping (China Pharmaceutical University), YANG Hong-jun (China Academy of Chinese Medical Sciences), XIAO Xiao-he (The Fifth Medical Center of PLA General Hospital), ZHANG Yun-ling (Xiyuan Hospital, China Academy of Chinese Medical Sciences), ZHANG Rong-hua (Jinan University), ZHANG Zhanjun (Beijing Normal University), LU Fu-er (Tongji Hospital, Huazhong University of Science and Technology), FAN Xiao-hui (College of Pharmaceutical Sciences, Zhejiang University), XIAN Shao-xiang (The First Affiliated Hospital, Guangzhou University of Chinese Medicine), XU Feng-qin (Xiyuan Hospital, China Academy of Chinese Medical Sciences), SHANG Hong-cai (Dongzhimen Hospital, Beijing University of Chinese Medicine), LIANG Chun (Changzheng Hospital, the Second Military Medical University), DAI Xiao-hua (Anhui Provincial Hospital of Traditional Chinese Medicine)

Consensus writing authors: LIU Yue (Xiyuan Hospital, China Academy of Chinese Medical Sciences), YANG Hua (China Pharmaceutical University), LIU Long-tao (Xiyuan Hospital, China Academy of Chinese Medical Sciences), FU Chang-geng (Xiyuan Hospital, China Academy of Chinese Medicine Sciences)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chinese Association of Integrative Medicine., Chinese Medical Doctor Association., National Clinical Research Center for Chinese Medicine Cardiology. et al. Chinese Expert Consensus on Clinical Application of Oral Ginkgo biloba Preparations (2020). Chin. J. Integr. Med. 27, 163–169 (2021). https://doi.org/10.1007/s11655-021-3289-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-021-3289-6

Search

Navigation